Bionika Pharmaceuticals
Private Company
Funding information not available
Overview
Bionika Pharmaceuticals is a private, revenue-generating pharmaceutical company operating as a commercial manufacturer and marketer of finished dosage forms. Its business model is centered on the production and sale of OTC pharmaceuticals and dietary supplements, with a pronounced strategic focus on women's health products. While not a traditional biotech R&D firm, it leverages formulation expertise to create products like hormone-free menopause support and immune-boosting supplements, serving markets primarily in the Balkan region and beyond. The company emphasizes quality manufacturing, partnerships, and a commitment to improving quality of life through accessible health products.
Technology Platform
Pharmaceutical formulation and GMP manufacturing of small molecule dosage forms, including combination products with probiotics/prebiotics and branded ingredient formulations.
Opportunities
Risk Factors
Competitive Landscape
Bionika competes in the broad OTC pharmaceutical and dietary supplement market, facing competition from multinational consumer health giants (e.g., Bayer, Johnson & Johnson, GSK) as well as numerous local and regional manufacturers. Its differentiation is based on targeted formulation (e.g., hormone-free menopause products), quality manufacturing, and a focus on specific regional health needs.